1-11 of 11
Iryna Kryachok
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Primary Mediastinal Large B-Cell Lymphoma: Insights from the Ukrainian Lymphoma Registry

Nazarii Shokun, Yana Stepanishyna, Iryna Tytorenko, Olena Aleksyk, Tetyana Kadnikova, Yan Pastushenko, Alevtyna Burtna, Timur Rudyuk, Natalia Shudrak, Katya Moiseienko, Tetiana Skrypets, Massimo Federico, Iryna Kryachok
Journal: Blood
Blood (2024) 144 (Supplement 1): 6427.
https://doi.org/10.1182/blood-2024-211079
Published: 2024
Journal Articles

Lisaftoclax (APG-2575) Demonstrates Activity and Safety When Given with Accelerated Ramp-up and then Combined with Acalabrutinib or Rituximab in Patients (pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Including Those with Prior Exposure to Venetoclax

Matthew S. Davids, Sikander Ailawadhi, Asher A. Chanan-Khan, Boyd Mudenda, Larysa Nogaieva, Iryna Kryachok, Ganna Usenko, Vladimir Ivanov, Olena Kyselova, Tetiana Perekhrestenko, Ivan Muzhychuk, Alexander Myasnikov, Les Lukavetsky, Andrei Proydakov, Olga Uspenskaya, Elena Borisenkova, Paula Marlton, Tanya Siddiqi, Allison M. Winter, Tamila Lysa, Bulat Akhatovich Bakirov, Tommy Fu, Mingyu Li, Mohammad Ahmad, Zi Chen, Zhiyan Liang, Divya J. Mekala, Olena Karpenko, Iurii Osipov, Asit De, Hengbang Wang, Nashat Gabrail, Vinod Ganju, Tatiana Konstantinova, Olga Samoilova, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2024) 144 (Supplement 1): 4614.
https://doi.org/10.1182/blood-2024-207408
Published: 2024
Journal Articles

Nemtabrutinib, a Noncovalent Reversible BTK Inhibitor in Relapsed or Refractory Follicular Lymphoma: Results from the Phase 2 Bellwave-003 Study

Wojciech Jurczak, Isabelle Fleury, Antonio Pinto, Sanne Lugthart, Omur Gokmen Sevindik, Iryna Kryachok, Elizabeth Phillips, Fei Li, Chan Y. Cheah, Jing Yang, Yan Xu, Siyang Leng, Fangfang Lv
Journal: Blood
Blood (2024) 144 (Supplement 1): 1634.
https://doi.org/10.1182/blood-2024-201578
Published: 2024
Journal Articles

High-Risk Subgroups and MRD: An Updated Analysis of the Phase 3 ECHO Trial of Acalabrutinib with Bendamustine/Rituximab in Previously Untreated Mantle Cell Lymphoma

Martin Dreyling, Jiri Mayer, David Belada, Yuqin Song, Wojciech Jurczak, Jonas Paludo, Michael P. Chu, Iryna Kryachok, Laura Maria Fogliatto, Chan Y. Cheah, Marta Morawska, Juan-Manuel Sancho, Yufu Li, Caterina Patti, Cecily Forsyth, Jingyang Zhang, Robin Lesley, Safaa Ramadan, Simon Rule, Michael Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 1626.
https://doi.org/10.1182/blood-2024-200290
Published: 2024
Journal Articles

A Prospective Ukrainian Multicentre Cohort Study of Pet Value Prognostic Role in Primary Patients with Hodgkin Lymphoma (HL): Six-Year a Brief Review

Olga Novosad, Iryna Kryachok, Olexandr Gorbach, Tymur Rudiuk, Ian Pastushenko, Yaroslav Kmetyuk, Olga Karpova, Larisa Mykhalska, Viktor Kozlov, Mykola Novikov, Olena Oliinichenko, Viktoriya Stratienko, Oksana Karnabeda, Andrey Ashykhmin, Tatyana Kadnikova, Natalia Shudrak
Journal: Blood
Blood (2023) 142 (Supplement 1): 6207.
https://doi.org/10.1182/blood-2023-180731
Published: 2023
Journal Articles

Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma

Emanuele Zucca, Luca Ceriani, Andrew S. Davies, Giovannino Ciccone, Umberto Ricardi, Alice Di Rocco, Iryna Kryachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Vittorio Ruggero Zilioli, Sara Usai, Luca Arcaini, Elsa Pennese, Anna Dabrowska-Iwanicka, Andrés José María Ferreri, Franceso Merli, Wei Li Zhao, David Hodgson, Codruta Ionescu, Luigi Rigacci, Claudia Cellini, Caterina Stelitano, Stefano Volpetti, Carla Minoia, Michele Spina, Alexander Fossa, George Mikhaeel, Kate Cwynarski, Andrea Janikova, Yana Stepanishyna, Mats Jerkeman, Andreas Huettmann, Maria Gomes da Silva, Don A. Stevens, Sally F Barrington, Bogdan Małkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Oreste Bagni, Kelly Cozens, Sonia Perticone, Nicoletta Ielmini, Letizia Deantonio, Jan Walewski, Marek Trneny, Mary Gospodarowicz, Franco Cavalli, Peter Johnson, Maurizio Martelli
Journal: Blood
Blood (2023) 142 (Supplement 1): 1718.
https://doi.org/10.1182/blood-2023-174093
Published: 2023
Journal Articles

Health-Related Quality of Life and Patient-Reported Outcomes in Patients Receiving Ofatumumab in Combination with Fludarabine and Cyclophosphamide (FC) Versus FC Alone in the Complement 2 Trial

Tadeusz Robak, MD Professor, Krzysztof Warzocha, MD PhD, K Govind Babu, Yaroslav Kulyaba, Kazimierz Kuliczkowski, Kudrat Abdulkadyrov, MD PhD, Javier Loscertales, Iryna Kryachok, Janusz Kloczko, Grygoriy Rekhtman, Wojciech Homenda, Jerzy Blonski, Astrid McKeown, PhD, Chai-Ni Chang, Stephanie C Manson, Steen Lisby, Ira V. Gupta, MD, Sebastian Grosicki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5288.
https://doi.org/10.1182/blood.V126.23.5288.5288
Published: 2015
Journal Articles

Ofatumumab (OFA) Vs. Physician’s Choice (PC) of Therapy in Patients (pts) with Bulky Fludarabine Refractory (BFR) Chronic Lymphocytic Leukaemia (CLL): Results of the Phase III Study OMB114242

Anders Österborg, Miklós Udvardy, Andrey Zaritskey, Per-Ola Andersson, Sebastian Grosicki, Grzegorz Mazur, Polina Kaplan, Michael Steurer, Anna Schuh, Marco Montillo, Iryna Kryachok, Jan Moritz Middeke, Yaroslav Kulyaba, Grygoriy Rekhtman, Michele Gorczyca, Siobhan Daly, Chang Chai-Ni, Steen Lisby, Ira Gupta
Journal: Blood
Blood (2014) 124 (21): 4684.
https://doi.org/10.1182/blood.V124.21.4684.4684
Published: 2014
Journal Articles

Key Results of International Randomized Open-Label Clinical Study of BCD-020 (rituximab biosimilar candidate) in Patients with B-Cell Non-Hodgkin’s Lymphoma

Kamil Kaplanov, Andrey Zaritskiy, MD, Sergey Alexeev, MD, PhD, Elena Volodicheva, Alexander Loginov, MD, Rashida Orlova, MD, PhD, Victoria Dvornichenko, MD, PhD, Marina Kosinova, MD, Olga Serduk, Vladimir Milovanov, MD, Alexander Myasnikov, MD PhD, Shekar Patil, MD, Shekar Patil, MD, Bharath Rangarajan, MD, Senthil Jagannathan Rajappa, MD DM, Minish Jain, MD, Sharanabasappa Nirni, MD, PhD, Akhil Deka, M, Grigoriy B Rekhtman, Iryna Kryachok, Zvenyslava Maslyak, Ekaterina Chernyaeva, MD, Roman Ivanov, MD, PhD, Alexander Isaev, MD
Journal: Blood
Blood (2014) 124 (21): 5467.
https://doi.org/10.1182/blood.V124.21.5467.5467
Published: 2014
Journal Articles

Low Frequency Of IGHV4-39/IGHD6-13/IGHJ5 Rearrangement With Stereotyped HCDR3 (subset #8) In Russian and Ukrainian Chronic Lymphocytic Leukemia Patients

Bella Biderman, Nadiia Bilous, Nataliya Severina, Andrey Sudarikov, Eugene Nikitin, Iryna Kryachok, Iryna Abramenko, Anatoliy Chumak
Journal: Blood
Blood (2013) 122 (21): 5276.
https://doi.org/10.1182/blood.V122.21.5276.5276
Published: 2013
Journal Articles

Analysis of TP53 Codon72, and p21 Codon31 Polymorphisms in CLL Patients Exposed to Ionizing Radiation Due to the Chernobyl NPP Accident

Nadiia Bilous, Iryna Abramenko, Anatoliy Chumak, Zoya Martina, Iryna Kryachok, Iryna Filonenko
Journal: Blood
Blood (2012) 120 (21): 4580.
https://doi.org/10.1182/blood.V120.21.4580.4580
Published: 2012